Cargando…

Severe Pulmonary Arterial Hypertension Is Characterized by Increased Neutrophil Elastase and Relative Elafin Deficiency

BACKGROUND: Preclinical evidence implicates neutrophil elastase (NE) in pulmonary arterial hypertension (PAH) pathogenesis, and the NE inhibitor elafin is under early therapeutic investigation. RESEARCH QUESTION: Are circulating NE and elafin levels abnormal in PAH and are they associated with clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sweatt, Andrew J., Miyagawa, Kazuya, Rhodes, Christopher J., Taylor, Shalina, Del Rosario, Patricia A., Hsi, Andrew, Haddad, Francois, Spiekerkoetter, Edda, Bental-Roof, Michal, Bland, Richard D., Swietlik, Emilia M., Gräf, Stefan, Wilkins, Martin R., Morrell, Nicholas W., Nicolls, Mark R., Rabinovitch, Marlene, Zamanian, Roham T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2021
Materias:	Pulmonary Vascular: Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546243/ https://www.ncbi.nlm.nih.gov/pubmed/34181952 http://dx.doi.org/10.1016/j.chest.2021.06.028

Ejemplares similares

The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
por: Haddad, Francois, et al.
Publicado: (2022)

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
por: Taylor, Shalina, et al.
Publicado: (2018)

Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival
por: Schwiening, Max, et al.
Publicado: (2022)

Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer
por: Hunt, Kelly K, et al.
Publicado: (2013)

THROMOEMBOLIC DISEASE: ONE OF MANY COMMON POST-COVID-19 COMPLICATIONS COMING SOON TO AN EMERGENCY ROOM NEAR YOU
por: BAIRD, ANDREW, et al.
Publicado: (2021)

Plasma Neutrophil Elastase and Elafin Imbalance Is Associated with Acute Respiratory Distress Syndrome (ARDS) Development
por: Wang, Zhaoxi, et al.
Publicado: (2009)

Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience
por: Hoole, Stephen P, et al.
Publicado: (2020)

Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response
por: Goh, Ze Ming, et al.
Publicado: (2022)

The Serine Protease Inhibitor Elafin Maintains Normal Growth Control by Opposing the Mitogenic Effects of Neutrophil Elastase
por: Caruso, Joseph A., et al.
Publicado: (2014)

Reply to Andréasson et al.: Multiple Manifestations of Systemic Sclerosis Affect Walk Distance
por: Zamanian, Roham T., et al.
Publicado: (2021)

Hemothorax after sneezing
por: Neff, Andrew, et al.
Publicado: (2023)

Prognostic value of TAPSE after therapy optimisation in patients with pulmonary arterial hypertension is independent of the haemodynamic effects of therapy
por: Ghio, Stefano, et al.
Publicado: (2016)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Fukui, Shigefumi, et al.
Publicado: (2016)

Right heart function during simulated altitude in patients with pulmonary arterial hypertension
por: Seccombe, Leigh M, et al.
Publicado: (2017)

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
por: Brook, Robert D, et al.
Publicado: (2017)

Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review
por: Varela, Daniel L, et al.
Publicado: (2018)

Rationale and design of the ranolazine PH–RV study: a multicentred randomised and placebo-controlled study of ranolazine to improve RV function in patients with non-group 2 pulmonary hypertension
por: Han, Yuchi, et al.
Publicado: (2018)

Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper
por: Abraham, Paul, et al.
Publicado: (2018)

Prognostic relevance of the right ventricular myo-mechanical index (RV-MMI) in patients with precapillary pulmonary hypertension
por: Greiner, Sebastian, et al.
Publicado: (2018)

Mechanisms of ECG signs in chronic obstructive pulmonary disease
por: Larssen, Marte Strømsnes, et al.
Publicado: (2017)

Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
por: Kim, Nick H, et al.
Publicado: (2017)

Oscillatory whole-body vibration improves exercise capacity and physical performance in pulmonary arterial hypertension: a randomised clinical study
por: Gerhardt, Felix, et al.
Publicado: (2017)

CENTRAL AND PERIPHERAL VENOUS THROMBOSIS IN NON-MECHANICALLY VENTILATED SURVIVORS OF COVID-19
por: Nauka, Peter, et al.
Publicado: (2020)

ACUTE PULMONARY EMBOLISM AND MYOCARDIAL INJURY IN COVID-19 PATIENT
por: Alfaki, Musaab, et al.
Publicado: (2020)

ANTICOAGULATION AND COVID-19: A META-ANALYSIS
por: Ho, Kam Sing, et al.
Publicado: (2020)

PULMONARY EMBOLISM AND RIGHT HEART STRAIN PATTERN IN COVID-19: AN INCIDENTAL FINDING OR A PERSISTENT PATTERN?
por: Roomi, Sohaib, et al.
Publicado: (2020)

PHLEGMASIA CERULEA DOLENS: AN ATYPICAL COVID-19 PRESENTATION
por: Akkari, Riad, et al.
Publicado: (2020)

MASSIVE PULMONARY EMBOLISM TREATED WITH THROMBOLYSIS IN COVID-19: A CASE SERIES
por: Alarcon-Calderon, Amarilys, et al.
Publicado: (2020)

COVID-19-ASSOCIATED COAGULOPATHY AS A PRESENTATION OF CORONAVIRUS DISEASE 2019: A PATIENT PRESENTS WITH A LARGE STROKE, PULMONARY EMBOLISM, AND DVT
por: Ramanathan, Rudra, et al.
Publicado: (2020)

Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase
por: DiNicolantonio, James J, et al.
Publicado: (2020)

Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19
por: Pagnesi, Matteo, et al.
Publicado: (2020)

Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension
por: Chouvarine, Philippe, et al.
Publicado: (2020)

Effects of oral sildenafil on exercise capacity in children with pulmonary arterial hypertension: a randomised trial
por: Russell, Stuart, et al.
Publicado: (2019)

Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registry
por: Minatsuki, Shun, et al.
Publicado: (2021)

COVID-19 AS A PRIMARY CAUSE OF PULMONARY ARTERIAL HYPERTENSION
por: RAVAL, ABHIJIT, et al.
Publicado: (2021)

SADDLE PULMONARY EMBOLISM WITH CRITICAL LIMB ISCHEMIA IN COVID-19
por: MAHGOUB, AHMED, et al.
Publicado: (2021)

UTILITY OF D-DIMER CUT-OFF POINT WITH VTE IN CRITICALLY ILL PATIENTS WITH COVID-19
por: ZHANG, RAINY, et al.
Publicado: (2021)

CASE REPORT OF A COVID-19 INFECTION AND THROMBOEMBOLISM IN A PATIENT WITH ULCERATIVE COLITIS ON TOFACITINIB
por: SOMPALLI, SREEJA, et al.
Publicado: (2021)

SICKLE CELL DISEASE AND COVID-19
por: HANNA, SANDRINE, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hl36f82qt11fgt61jr754i0c4r